Joel D. Liffman

Joel D. Liffman discloses dealings in Precigen, Inc. to SEC (Form 4). Between 12 December 2016 and 4 January 2019, the trades on record add up to 5 filings.

Market trades split into 1 purchase (€231k) and 2 sales (€1.0M). Sales outweigh purchases by €787k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant and 1 option exercise. In 2019 alone, the filings show no purchases and 1 sale.

The newest entry dates from 8 January 2019: a share grant, in Precigen, Inc. The most recent open-market purchase was published on 13 December 2016, 3,618 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.